Trial
NCT06110598
CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X)
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Case Comprehensive Cancer Center
Collaborators
—
Condition
Pancreas Cancer
Intervention
Capecitabine
Why stopped
PI left the institution
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-15